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Letters to the Editorplaced patients with preoperative PaO2
as low as 55 mm Hg, simple oxygen
addition by a Venturi mask assured an
optimal oxygenation throughout the
procedure. This is possibly facilitated
by the maintained diaphragmatic mo-
tion as well as by suprapontine com-
pensatory mechanisms.
Increasing pathophysiologic knowl-
edge and clinical evidence suggest
that general anesthesia is not always
necessary in thoracic surgery, and in
some patient populations awake anes-
thesia can offer a lessmorbid, paraphy-
siologic model of management. We
congratulate Noda and coworkers1 for
their interesting series with excellent
results and cautious conclusions.
Eugenio Pompeo, MD
For the Awake Thoracic Surgery
Research Group
Department of Thoracic Surgery
Policlinico Tor Vergata University
Rome, Italy
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We appreciate the useful comments
expressed by Dr Pompeo on behalf of
the Awake Thoracic Surgery Research
Group regardingour recentlypublished
original article entitled, ‘‘Is There
a Benefit of Awake Thoracoscopic
Surgery in Patients With Secondary
Spontaneous Pneumothorax?’’1 We
are grateful for the opportunity to re-
spond to these comments.
We agree that severe air trapping at-
tenuates the effect of atmospheric282 The Journal of Thoracic and Cintrapleural pressure on ventilation as
a result of prolonged exhalation times
and the existence of positive end-
expiratory pressures in peripheral alve-
olar regions that may counteract the
detrimental effects of pendular ventila-
tion during the awake procedure.
Moreover, we have reported a case
of intractable right pneumothorax
after left pneumonectomy that was
successfully treated with awake
video-assisted thoracoscopic surgery
under conditions of local and epidural
anesthesia.2 In this case, the patient
maintained spontaneous single-lung
breathing throughout the operation
with supplied oxygen to maintain
functional oxygen saturation greater
than 94% because of the prolonged
exhalation times and existence of
positive end-expiratory pressures in
1 lung.
Although there are a few excep-
tions, if the lung collapse is extremely
progressed under atmospheric pres-
sure conditions and desaturation is re-
corded during the awake procedure,
the lung should be temporarily re-
expanded by sucking the air in the
pleural cavity through the chest drain-
age tube.
The vital issue in awake thoracic
procedure is the surgical position.
Our awake thoracic procedure for in-
tractable pneumothorax is generally
conducted in the lateral surgical posi-
tion, with most of the bubbling alveo-
lar air leakage managed by sucking
the air through the chest drainage
tube because the air leakage sites can
be immediately identified during the
awake procedure. If the patients have
shoulder or lumbar pain on the contra-
lateral side during awake procedure in
the lateral position, the position may
be gradually altered to a semilateral
or supine position.
Moreover, in patients undergoing
awake thoracic procedures for pneu-
mothorax, the surgical technique for
controlling air leakage is vital for pre-
venting a recurrence. In all our patients
with pneumothorax, the area of ligation
or the staple line was reinforced withardiovascular Surgery c July 2012nonwoven polyglycolic acid sheets
(NEOVEIL; Gunze Co, Ayabe, Japan)
or regenerated oxidized cellulose
mesh (Surgicel; Ethicon, Inc, Somer-
ville, NJ) and fibrin glue (Bolheal;
Chemo-Sero-Therapeutic Research In-
stitute, Kumamoto, Japan).3 This
mechanism facilitates thickening of
the visceral pleural surface.4
We thank Dr Pompeo and his group for
their informative and encouraging com-
ments on the awake surgical management
of secondary pneumothorax.
Masafumi Noda, MD, PhD
Yoshinori Okada, MD, PhD
Takashi Kondo, MD, PhD
Department of Thoracic Surgery
Institute of Development, Aging, and
Cancer
Tohoku University
Sendai, Japan
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AMBULATORY VENO-VENOUS
EXTRACORPOREAL
MEMBRANE OXYGENATION
To the Editor:
We read with great interest the
recently publishedwork entitled, ‘‘Am-
bulatory Veno-Venous Extracorporeal
Oxygenation: Innovations and Pit-
falls,’’ from the Maryland extracorpo-
real membrane oxygenation group.1
First, we congratulate Garcia and
colleagues1 on their clear article,
Letters to the Editorindicating an important step toward
facilitated mobilization on extracor-
poreal pulmonary support. They de-
scribed their experience with a new
medical device, a double-lumen can-
nula for single-vessel access in adults
that is introduced through the right
jugular vein.
Our group in Regensburg, Ger-
many, has gained an extensive experi-
ence in extracorporeal life support
during the last decade, with currently
more than 500 extracorporeal mem-
brane oxygenation cases for respira-
tory and cardiac support. The Avalon
double-lumen cannula (Avalon Labo-
ratories, LLC, Rancho Dominguez,
Calif) for respiratory support was in-
troduced in our institution in 2009.
As of this writing, 40 patients in our
institution have been equipped with
this double-lumen catheter. We there-
fore appreciate the opportunity for
some remarks regarding the work of
Garcia and colleagues.1
Similar to the Maryland group, we
strongly recommend visual guidance
during the implantation of the
double-lumen cannula. Cannula
placement has the potential to be
harmful, damaging crucial structures,
including the great veins and the heart.
Garcia and colleagues1 described ad-
vancing the tip of the guidewire 2
cm into the inferior vena cava. Our
group prefers advancing the guidewire
down to the iliac veins if possible, to
minimize the risk of guidewire dislo-
cation during implantation of the ac-
tual cannula.
We were surprised and at the same
time encouraged by the fact that
veno-venous support was used suc-
cessfully in patients with right ventric-
ular failure, because veno-arterial
support is generally the preferred
mode for the failing right ventricle.
Garcia and colleagues1 did not com-
ment on this new approach in detail.
Apparently, in some patients an atrial
septal defect was present, acting as
a pop-off shunt for the right ventricle.
Garcia and colleagues1 noted that
they did not use the double-lumenThe Journalcannula in patients with a body sur-
face area greater than 2.0 m2. Our
group has seen a special advantage
in the use of the double-lumen cathe-
ters, especially in morbidly obese pa-
tients with a body surface area
greater than 2.0 m2 and a body mass
index greater than 40 kg/m2, because
cannulation of the internal jugular
vein in this patient population is often
still possible.
We also remark on the displayed
gas transfer. In screening our data-
base, we found the recorded gas trans-
fer rates to have a mean between 200
and 300 mL/min. We have never cal-
culated values above 500 mL/min,
however, and according to the manu-
facturer a gas transfer of 529 mL/
min with the Quadrox oxygenator
(Maquet Medical Systems USA,
Wayne, NJ) is virtually impossible.2
We congratulate Garcia and col-
leagues1 for their approach to tunnel-
ing the cannula in the neck to
prevent infection and dislocation. On
the other hand, we are concerned as
to whether the correct placement of
the cannula might be hindered by tun-
neling the cannula.
Last but not least, Garcia and col-
leagues1 have described an important
and significant step toward ambula-
tory lung support that might be appli-
cable in the future on an outpatient
level. For now, however, ambulation
on extracorporeal membrane oxygen-
ation is only possible in intensive
care settings.
Daniele Camboni, MDa
Alois Philippa
Thomas Mueller, MDb
Christof Schmid, MDa
aDepartment of Cardiothoracic
Surgery
bDepartment of Internal Medicine II,
University Hospital Regensburg
Regensburg, Germany
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doi:10.1016/j.jtcvs.2011.12.068Reply to the Editor:
We greatly appreciate the com-
ments by Camboni and colleagues in
response to our early experience with
ambulatory extracorporeal membrane
oxygenation. Although the avoidance
of groin cannulation with the use of
a dual-lumen, single-cannula system
for extracorporeal membrane oxygen-
ation is a critical component, we
prefer to view ambulatory extracorpo-
real membrane oxygenation as an
overall treatment strategy, rather than
simply the use of a new device. We
believe that reducing mechanical
ventilatory support and encouraging
ambulation to minimize ventilator-
induced lung injury and decondition-
ing are vital to better outcomes in
this patient population.
In response to the comments con-
cerning cannula placement, we agree
that for safe cannula placement, the fi-
nal stiff guidewire should be placed
into the iliac veins; however, our prac-
tice is to place an initial soft guidewire
into the inferior vena cava. A catheter
is then placed over the soft guidewire
at least 2 cm into the inferior vena
cava. The soft guidewire is then ex-
changed for a stiff guidewire, which
is then advanced to the iliac veins for
placement of the cannula. This extra
step allows easier and safer advance-
ment of a stiff guidewire across the
right atrial–inferior vena caval junc-
tion.Moreover, in light of anecdotal re-
ports of atrial perforation with cannula
displacement duringpatientmovement
in other centers, we favor tunneling the
catheter whenever possible. In our ex-
perience, which has been guided by
the use of fluoroscopy and transeso-
phageal echocardiography, tunneling
the catheter has not resulted in any dif-
ficulty with catheter positioning.
The Regensburg group also makes
a prudent observation with regard tory c Volume 144, Number 1 283
